Describe who is not a candidate for hormone replacement therapy?
Previous references used if they are helpful:
Arnson, Y., Rozanski, A., Gransar, H., Otaki, Y., Doris, M., Wang, F., … & Slomka, P. (2017). Hormone replacement therapy is associated with less coronary atherosclerosis and lower mortality. Journal of the American College of Cardiology, 69(11 Supplement), 1408.
Baber, R. J., Panay, N., & Fenton, A. T. I. W. G. (2016). 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric, 19(2), 109-150.
Hawkins, J., Roberto-Nicholas,D. & Stanley-Haney, J. (2016). Guidelines for Nurse Practitioners in Gynecologic Settings (11th ed.). New York, NY: Springer Publishing. ISBN-13: 978-0826122827
Kotsopoulos, J., Huzarski, T., Gronwald, J., Moller, P., Lynch, H. T., Neuhausen, S. L., … & Karlan, B. (2016). Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: A case–control study. Breast cancer research and treatment, 155(2), 365-373.
Lobo, R. A., Pickar, J. H., Stevenson, J. C., Mack, W. J., & Hodis, H. N. (2016). Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis, 254, 282-290.
Manson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., … & Lewis, C. E. (2017). Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women’s Health Initiative randomized trials. Jama, 318(10), 927-938.
Mayo Clinic Staff, (2018). Hormone therapy, is it right for you? Retrieved from http://www.mayoclinic.org/diseases-conditions/menopause/in-depth/hormone-therapy/art-20046372
National Institute for Health and Care Excellence [NICE], (2015). Long term risk and benefits of hormone replacement therapy. Retrieved from https://www.hcbi.nlm.nih.gov/books/NBK343458
Schuiling, K. D. & Likis, F. E. (2016). Women’s Gynecologic Health (3rd ed.). Sudbury, MA: Jones & Bartlett. ISBN: 9781284076028